SlideShare a Scribd company logo
1 of 9
Interventional Cardiology Devices
Markets WorldwideMarkets Worldwide
Report Highlights
October 2011
Report Benefits
This report can help in:
• Assessing the market for Interventional Cardiology Devices
worldwide, growth segments, and growth regions.
• Understanding market drivers and restraints, market• Understanding market drivers and restraints, market
segmentation, and competitive segmentation.
• Strategic planning and competitive strategy.
• Identifying opportunities for partnerships and alliances.
2© 2011 Marketstrat, Inc., All Rights Reserved
Key Takeaways
• The world market for interventional cardiology devices comprised of coronary and carotid stents,
atherectomy devices, PTCA catheters, angiographic and guiding catheters is about $9.7 billion
growing at a CAGR of 8.7 percent over the next few years.
• Primary drivers include growing patient population and demand for PCI; new imaging technology
like IVUS that greatly enhances diagnosis and guidance; improving reimbursement and favorable
large-scale, long-term clinical studies and sky-rocketing demand in emerging healthcare markets.
• Primary restraints include post-treatment complications in the longer term, technical complexities• Primary restraints include post-treatment complications in the longer term, technical complexities
and availability of trained clinicians, and intense competition.
• Market opportunities include expansion in emerging markets, particularly China where growth of
many segments is between 20 to 30 percent; new technology launches including carotid stents, bio-
absorbable DES and devices for smaller vessels and peripheral artery disease.
• Leaders are Boston Scientific, Abbott Vascular, Cordis, Medtronic and ev3/ Covidien. Innovators
include Volcano Corp., Cardiovascular Systems Inc., Pathway Medical, Spectranetics, Reva Medical,
and Angioscore, among others.
October 11 3© 2011 Marketstrat, Inc., All Rights Reserved
Sample Data Table
JAPAN - DES CORONARY STENTS MARKET - REVENUE FORECASTS ($ Million, 2010-2018)
Year Revenues ($ Million) % of Japanese Mkt Growth (%)
2010 $433.24 39.90%
2011 $433.64 38.58% 0.09% 0.10%
2012 $434.06 37.23% 0.10% 0.11%
2013 $434.56 35.85% 0.11% 0.13%
2014 $435.07 34.46% 0.12% 0.15%
2015 $435.62 33.05% 0.13% 0.18%
© 2011 Marketstrat, Inc., All Rights Reserved 4
2015 $435.62 33.05% 0.13% 0.18%
2016 $436.25 31.62% 0.14% 0.21%
2017 $436.91 30.17% 0.15% 0.25%
2018 $437.62 28.72% 0.16% 0.33%
CAGR 0.1% 0.2%
Notes:
1. Includes drug-elutingcoronary stents
2. Data are at the manufacturer level
Source: Marketstrat®
Sample Data Table
World - ATHERECTOMY DEVICES -Revenue Forecasts by Country/Region - 2010-2018 ($ Mill)
Segment 2010 2011 2012 2013 2014 2015 2016 2017 2018 CAGR
USA
% of world market
CANADA
% of world market
LATAM
% of world market
FRANCE
% of world market
GERMANY
% of world market
UK
© 2011 Marketstrat, Inc., All Rights Reserved 5
UK
% of world market
ITALY
% of world market
JAPAN
% of world market
CHINA
% of world market
INDIA
% of world market
ROW
% of world market
TOTAL ($ Mill)
GROWTH (%)
2. Data a re a t the ma nufacturer level
Source: Marketstrat®
Notes :
1. Includes rota tiona l, excisional a nd la ser corona ry a therectomy devices
Sample Data Chart
WORLD - CAROTID STENTS MARKET - REVENUE FORECASTS (2010-2018, $ MILL)
12.0%
14.0%
16.0%
18.0%
20.0%
$8,000.0
$10,000.0
$12,000.0
%Growth
Revenues($Million)
© 2011 Marketstrat, Inc., All Rights Reserved 6
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
$0.0
$2,000.0
$4,000.0
$6,000.0
$8,000.0
2010 2011 2012 2013 2014 2015 2016 2017 2018
%Growth
Revenues($Million)
Revenues ($ Mill) Growth (%)
Report Stats
Category Detail
Regions Covered United States; Canada; LATAM, Germany, France, UK, Italy,
Japan, China, India; Rest of the World (ROW)
Product/Market
Segments
• Coronary Stents – Drug Eluting (DES) and Bare Metal(BMS)
• Carotid Stents
• Atherectomy devices
• PTCA (percutaneous transluminal coronary angioplasty)
balloon catheters – Monorail/ rapid exchange (Rx) and Over-balloon catheters – Monorail/ rapid exchange (Rx) and Over-
the-wire (OTW)
• Angiography and Guiding Catheters
Company Profiles 110+ Companies
Market Estimates/
Forecasts
2010-2018
Report Code 325-11
Price $2995 (single-user license); $5990 (corporate license)
No. of Pages 474 pages; 230 data tables; 222 charts
Publication Date October 2011
© 2011 Marketstrat, Inc., All Rights ReservedOctober 11 7
About Us
Marketstrat specializes in Medical Market Research. We assist companies
with market, technology, and best practice strategies & intelligence,
through a unique combination of published reports, solutions, and
services.
Our strengths include: a deep understanding of the medical devices valueOur strengths include: a deep understanding of the medical devices value
chain, state-of-the-art data collection tools, and a robust research
methodology.
4695 Chabot Drive, Suite 200
Pleasanton, CA 94588, USA.
Email : info@marketstrat.com
Phone: 925-263-4455
Fax: 925-263-4456
www.marketstrat.com
October 11 © 2011 Marketstrat, Inc., All Rights Reserved 8
October 11 9© 2011 Marketstrat, Inc., All Rights Reserved

More Related Content

Viewers also liked

Aicd in asian settings ppt
Aicd in asian settings pptAicd in asian settings ppt
Aicd in asian settings pptPavan Rasalkar
 
CTO vs Medical management
CTO vs Medical managementCTO vs Medical management
CTO vs Medical managementPavan Rasalkar
 
ESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationtheheart.org
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua Hiralal Pawar
 
Acs biomark final
Acs biomark finalAcs biomark final
Acs biomark finalRavi Kanth
 
Oral anticoagulation in AF
Oral anticoagulation in AFOral anticoagulation in AF
Oral anticoagulation in AFPavan Rasalkar
 
Dabigatran
DabigatranDabigatran
Dabigatranhospital
 
Acs anticoagulation
Acs anticoagulationAcs anticoagulation
Acs anticoagulationVivek Rana
 
Tachyarrhtymia induced cardiomyopathy
Tachyarrhtymia induced cardiomyopathyTachyarrhtymia induced cardiomyopathy
Tachyarrhtymia induced cardiomyopathyPavan Rasalkar
 
Thrombus aspiration in ppci
Thrombus aspiration in ppciThrombus aspiration in ppci
Thrombus aspiration in ppciPavan Rasalkar
 
Cardiology board images
Cardiology board imagesCardiology board images
Cardiology board imageshospital
 
Basics of adult congenital heart disease assessment
Basics of adult congenital heart disease assessmentBasics of adult congenital heart disease assessment
Basics of adult congenital heart disease assessmentoussama El-h
 
Cardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyCardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyhospital
 
Ecg test 2
Ecg test 2Ecg test 2
Ecg test 2hospital
 
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMNewer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMDeepak Arjun
 
Problem associated with drug eluting stent
Problem associated with drug eluting stentProblem associated with drug eluting stent
Problem associated with drug eluting stentPRAVEEN GUPTA
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionJunhao Koh
 

Viewers also liked (20)

Aicd in asian settings ppt
Aicd in asian settings pptAicd in asian settings ppt
Aicd in asian settings ppt
 
CTO vs Medical management
CTO vs Medical managementCTO vs Medical management
CTO vs Medical management
 
ESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentation
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua
 
Acs biomark final
Acs biomark finalAcs biomark final
Acs biomark final
 
Oral anticoagulation in AF
Oral anticoagulation in AFOral anticoagulation in AF
Oral anticoagulation in AF
 
Dabigatran
DabigatranDabigatran
Dabigatran
 
NO REFLOW
NO REFLOWNO REFLOW
NO REFLOW
 
Acs anticoagulation
Acs anticoagulationAcs anticoagulation
Acs anticoagulation
 
Tachyarrhtymia induced cardiomyopathy
Tachyarrhtymia induced cardiomyopathyTachyarrhtymia induced cardiomyopathy
Tachyarrhtymia induced cardiomyopathy
 
Thrombus aspiration in ppci
Thrombus aspiration in ppciThrombus aspiration in ppci
Thrombus aspiration in ppci
 
Brugada
BrugadaBrugada
Brugada
 
Vsd device closure
Vsd device closureVsd device closure
Vsd device closure
 
Cardiology board images
Cardiology board imagesCardiology board images
Cardiology board images
 
Basics of adult congenital heart disease assessment
Basics of adult congenital heart disease assessmentBasics of adult congenital heart disease assessment
Basics of adult congenital heart disease assessment
 
Cardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyCardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copy
 
Ecg test 2
Ecg test 2Ecg test 2
Ecg test 2
 
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMNewer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
 
Problem associated with drug eluting stent
Problem associated with drug eluting stentProblem associated with drug eluting stent
Problem associated with drug eluting stent
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic Function
 

Recently uploaded

MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhangmcgroupjeya
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.ukaroemirsr
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003believeminhh
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfHajeJanKamps
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 

Recently uploaded (20)

MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhang
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.uk
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 

World Interventional Cardiology Devices Market

  • 1. Interventional Cardiology Devices Markets WorldwideMarkets Worldwide Report Highlights October 2011
  • 2. Report Benefits This report can help in: • Assessing the market for Interventional Cardiology Devices worldwide, growth segments, and growth regions. • Understanding market drivers and restraints, market• Understanding market drivers and restraints, market segmentation, and competitive segmentation. • Strategic planning and competitive strategy. • Identifying opportunities for partnerships and alliances. 2© 2011 Marketstrat, Inc., All Rights Reserved
  • 3. Key Takeaways • The world market for interventional cardiology devices comprised of coronary and carotid stents, atherectomy devices, PTCA catheters, angiographic and guiding catheters is about $9.7 billion growing at a CAGR of 8.7 percent over the next few years. • Primary drivers include growing patient population and demand for PCI; new imaging technology like IVUS that greatly enhances diagnosis and guidance; improving reimbursement and favorable large-scale, long-term clinical studies and sky-rocketing demand in emerging healthcare markets. • Primary restraints include post-treatment complications in the longer term, technical complexities• Primary restraints include post-treatment complications in the longer term, technical complexities and availability of trained clinicians, and intense competition. • Market opportunities include expansion in emerging markets, particularly China where growth of many segments is between 20 to 30 percent; new technology launches including carotid stents, bio- absorbable DES and devices for smaller vessels and peripheral artery disease. • Leaders are Boston Scientific, Abbott Vascular, Cordis, Medtronic and ev3/ Covidien. Innovators include Volcano Corp., Cardiovascular Systems Inc., Pathway Medical, Spectranetics, Reva Medical, and Angioscore, among others. October 11 3© 2011 Marketstrat, Inc., All Rights Reserved
  • 4. Sample Data Table JAPAN - DES CORONARY STENTS MARKET - REVENUE FORECASTS ($ Million, 2010-2018) Year Revenues ($ Million) % of Japanese Mkt Growth (%) 2010 $433.24 39.90% 2011 $433.64 38.58% 0.09% 0.10% 2012 $434.06 37.23% 0.10% 0.11% 2013 $434.56 35.85% 0.11% 0.13% 2014 $435.07 34.46% 0.12% 0.15% 2015 $435.62 33.05% 0.13% 0.18% © 2011 Marketstrat, Inc., All Rights Reserved 4 2015 $435.62 33.05% 0.13% 0.18% 2016 $436.25 31.62% 0.14% 0.21% 2017 $436.91 30.17% 0.15% 0.25% 2018 $437.62 28.72% 0.16% 0.33% CAGR 0.1% 0.2% Notes: 1. Includes drug-elutingcoronary stents 2. Data are at the manufacturer level Source: Marketstrat®
  • 5. Sample Data Table World - ATHERECTOMY DEVICES -Revenue Forecasts by Country/Region - 2010-2018 ($ Mill) Segment 2010 2011 2012 2013 2014 2015 2016 2017 2018 CAGR USA % of world market CANADA % of world market LATAM % of world market FRANCE % of world market GERMANY % of world market UK © 2011 Marketstrat, Inc., All Rights Reserved 5 UK % of world market ITALY % of world market JAPAN % of world market CHINA % of world market INDIA % of world market ROW % of world market TOTAL ($ Mill) GROWTH (%) 2. Data a re a t the ma nufacturer level Source: Marketstrat® Notes : 1. Includes rota tiona l, excisional a nd la ser corona ry a therectomy devices
  • 6. Sample Data Chart WORLD - CAROTID STENTS MARKET - REVENUE FORECASTS (2010-2018, $ MILL) 12.0% 14.0% 16.0% 18.0% 20.0% $8,000.0 $10,000.0 $12,000.0 %Growth Revenues($Million) © 2011 Marketstrat, Inc., All Rights Reserved 6 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% $0.0 $2,000.0 $4,000.0 $6,000.0 $8,000.0 2010 2011 2012 2013 2014 2015 2016 2017 2018 %Growth Revenues($Million) Revenues ($ Mill) Growth (%)
  • 7. Report Stats Category Detail Regions Covered United States; Canada; LATAM, Germany, France, UK, Italy, Japan, China, India; Rest of the World (ROW) Product/Market Segments • Coronary Stents – Drug Eluting (DES) and Bare Metal(BMS) • Carotid Stents • Atherectomy devices • PTCA (percutaneous transluminal coronary angioplasty) balloon catheters – Monorail/ rapid exchange (Rx) and Over-balloon catheters – Monorail/ rapid exchange (Rx) and Over- the-wire (OTW) • Angiography and Guiding Catheters Company Profiles 110+ Companies Market Estimates/ Forecasts 2010-2018 Report Code 325-11 Price $2995 (single-user license); $5990 (corporate license) No. of Pages 474 pages; 230 data tables; 222 charts Publication Date October 2011 © 2011 Marketstrat, Inc., All Rights ReservedOctober 11 7
  • 8. About Us Marketstrat specializes in Medical Market Research. We assist companies with market, technology, and best practice strategies & intelligence, through a unique combination of published reports, solutions, and services. Our strengths include: a deep understanding of the medical devices valueOur strengths include: a deep understanding of the medical devices value chain, state-of-the-art data collection tools, and a robust research methodology. 4695 Chabot Drive, Suite 200 Pleasanton, CA 94588, USA. Email : info@marketstrat.com Phone: 925-263-4455 Fax: 925-263-4456 www.marketstrat.com October 11 © 2011 Marketstrat, Inc., All Rights Reserved 8
  • 9. October 11 9© 2011 Marketstrat, Inc., All Rights Reserved